Cost-utility Analysis of Rhegmatogenous Retinal Detachment Surgery in Shanghai, China

References

• Mitry D, Charteris DG, Fleck BW, et al. The epidemiology of rhegmatogenous retinal detachment: geographical variation and clinical associations. Br J Ophthalmol 2009;94:678–684
   PubMed Web of Science ®Google Scholar
• Zou H, Zhang X, Xu X, et al. Epidemiology survey of rhegmatogenous retinal detachment in Beixinjing District, Shanghai, China. Retina 2002;22:294–299
   PubMed Web of Science ®Google Scholar
• Ross WH, Stockl FA. Visual recovery after retinal detachment. Curr Opin Ophthalmol 2000;11:191–194
   PubMedGoogle Scholar
• Zou H, Zhang X, Xu X, Liu H. Quality of life in subjects with rhegmatogenous retinal detachment. Ophthal Epidemiol 2008;15:212–217
   PubMed Web of Science ®Google Scholar
• Huang XB, Zou HD, Wang N, et al. A prevalence survey of blindness and visual impairment in adults aged equal or more than 60 years in Beixinjing blocks of Shanghai, China. Chin J Ophthamol 2009;45:786–792
   Google Scholar
• Zou H, Zhang X, Xu X, et al. Vision-related quality of life and self-rated satisfaction outcomes of rhegmatogenous retinal detachment surgery: 3-year prospective study. PLoS ONE 2011;6(12):e28597
   Google Scholar
• Brown GC, Brown MM, Sharma S, et al. A cost-utility analysis of interventions for severe proliferative vitreoretinopathy. Am J Ophthalmol 2002;133:365–372
   PubMed Web of Science ®Google Scholar
• Brown G C. Vision and quality of life. Trans Am Ophthalmol Soc 1999;97:473–511
   PubMedGoogle Scholar
• Muennig P. Cost-effectiveness analyses in health: a practical approach. New York, NY: John Wiley & Sons, 2008
   Google Scholar
• Brown MM, Brown GC, Sharma S, Garrett S. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol 1999;10:221–226
   PubMedGoogle Scholar
• Kymes SM, Lee BS. Preference-based quality of life measures in people with visual impairment. Optom Vis Sci 2007;84:809–816
   PubMed Web of Science ®Google Scholar
• Brown GC, Brown MM, Sharma S, et al. Value-based medicine and ophthalmology: an appraisal of cost-utility analyses. Trans Am Ophthalmol Soc 2004;102:177–188
   PubMedGoogle Scholar
• Zou H, Zhang X, Xu X, et al. Utility value and retinal detachment surgery. Ophthalmology 2011;118:601
   PubMed Web of Science ®Google Scholar
• Sharma S, Brown GC, Brown MM, et al. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol 2002;86:493–496
   PubMed Web of Science ®Google Scholar
• Knauer C, Pfeiffer N. The value of vision. Graefes Arch Clin Exp Ophthalmol 2008;246:477–482
   PubMed Web of Science ®Google Scholar
• Stein JD. Disparities between ophthalmologists and their patients in estimating quality of life. Curr Opin Ophthalmol 2004;15:238–243
   PubMedGoogle Scholar
• Stein JD, Brown MM, Brown GC, et al. Quality of life with macular degeneration: perceptions of patients, clinicians, and community members. Br J Ophthalmol 2003;87:8–12
   PubMed Web of Science ®Google Scholar
• National Bureau of Statistics of China. Statistical Communiqué of the People’s Republic of China. Available from: http://www.stats.gov.cn/tjgb/ [last accessed Feb 2012].
   Google Scholar
• Shanghai Population and Birthcontrol Committee. The tenth five year programme of birthcontrol and population development in Shanghai. Available from:http://www.popinfo.gov.cn/ Accessed April 2008.
   Google Scholar
• Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999;3:1–134
   PubMedGoogle Scholar
• Polsky D, Glick H A, Willke R. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Econ 1997;6:243–252
   PubMed Web of Science ®Google Scholar
• Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000;19:3219–3236
   PubMed Web of Science ®Google Scholar
• Drummond MF. Methods for the economic evaluation of Health Care Programmes. Oxford: Oxford University Press, 2005
   Google Scholar
• van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994;3:309–319
   PubMed Web of Science ®Google Scholar
• Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779–787
   PubMed Web of Science ®Google Scholar
• Commission on Macroeconomics and Health of WHO. Report on Macroeconomics and Health: Investing in Health for Economic Development. Geneva: WHO, 2001
   Google Scholar
• Xie X, Vondeling H. Cost-utility analysis of intensive blood glucose control with metformin versus usual care in overweight type 2 diabetes mellitus patients in Beijing, P.R. China. Value Health 2008;11(Suppl. 1):S23–32
   PubMed Web of Science ®Google Scholar
• Yang L, Christensen T, Sun F, Chang J. Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study. Value Health 2012;15(1 Suppl.):S56–S59
   PubMed Web of Science ®Google Scholar
• Rachapelle S, Legood R, Alavi Y, et al. The cost-utility of telemedicine to screen for diabetic retinopathy in India. Ophthalmology 2013;120:566–573
   PubMed Web of Science ®Google Scholar
• Saw SM, Gazzard G, Au Eong KG, et al. Utility values in Singapore Chinese adults with primary open-angle and primary angle-closure glaucoma. J Glaucoma 2005;14:455–462
   PubMed Web of Science ®Google Scholar
• Au Eong KG, Chan EW, Luo N, et al. Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population. Eye (Lond) 2012;26:379–388
   PubMed Web of Science ®Google Scholar
• Barbieri M, Drummond M, Willke R, et al. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability. Value Health 2005;8:10–23
   PubMed Web of Science ®Google Scholar
• Sodhi A, Leung LS, Do DV, et al. Recent trends in the management of rhegmatogenous retinal detachment. Surv Ophthalmol 2008;53:50–67
   PubMed Web of Science ®Google Scholar
• D’Amico DJ. Primary retinal detachment. N Engl J Med 2008;359:2346–2354
   PubMed Web of Science ®Google Scholar
• Torrance GW. Social preferences for health states: an empirical evaluation of three measurement techniques. Soc Sci Med 1976;10:129–136
   PubMed Web of Science ®Google Scholar